Consolidated Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7586679

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
96,434,000,000 JPY
JPY
JPY
JPY
96,434,000,000 JPY
96,434,000,000 JPY
JPY
71,623,000,000 JPY
JPY
JPY
JPY
JPY
71,609,000,000 JPY
JPY
JPY
71,609,000,000 JPY
JPY
JPY
JPY
JPY
JPY
40,922,000,000 JPY
71,609,000,000 JPY
Impairment losses (reversal of impairment losses)
22,768,000,000 JPY
26,054,000,000 JPY
Decrease (increase) in inventories
113,000,000 JPY
15,423,000,000 JPY
Other
5,893,000,000 JPY
16,768,000,000 JPY
Subtotal
175,052,000,000 JPY
163,451,000,000 JPY
Income taxes paid
-35,195,000,000 JPY
-24,066,000,000 JPY
Net cash provided by (used in) operating activities
139,857,000,000 JPY
139,385,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-13,795,000,000 JPY
-17,493,000,000 JPY
Purchase of intangible assets
-25,894,000,000 JPY
-30,382,000,000 JPY
Payments for acquisition of subsidiaries
JPY
-649,000,000 JPY
Other
-8,268,000,000 JPY
-7,955,000,000 JPY
Net cash provided by (used in) investing activities
-34,660,000,000 JPY
-55,744,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-10,553,000,000 JPY
-715,000,000 JPY
Other
-1,348,000,000 JPY
-1,224,000,000 JPY
Net cash provided by (used in) financing activities
-81,431,000,000 JPY
-89,936,000,000 JPY
Cash and cash equivalents
361,073,000,000 JPY
315,986,000,000 JPY
318,295,000,000 JPY
326,128,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
21,321,000,000 JPY
-1,539,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.